Article
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.
Journal of the National Cancer Institute - 29 Nov 2021
Ceyhan-Birsoy Ozge, Selenica Pier, Chui M Herman, Jayakumaran Gowtham, Ptashkin Ryan, Misyura Maksym, Aypar Umut, Jairam Sowmya, Yang Ciyu, Li Yirong, Mehta Nikita, Kemel Yelena, Salo-Mullen Erin, Maio Anna, Sheehan Margaret, Zehir Ahmet, Carlo Maria, Latham Alicia, Stadler Zsofia, Robson Mark, Offit Kenneth, Ladanyi Marc, Walsh Michael, Reis-Filho Jorge S, Mandelker Diana
Abstract excerpt
BACKGROUND: Genetic testing for Li-Fraumeni syndrome (LFS) is performed by using blood specimens from patients selected based on phenotype-dependent guidelines. This approach is problematic for understanding the LFS clinical spectrum because patients with nonclassical presentations are missed, clonal hematopoiesis-related somatic blood alterations cannot be distinguished from germline variants, and unrelated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
